PMID- 33307974 OWN - NLM STAT- MEDLINE DCOM- 20211213 LR - 20220202 IS - 1557-8534 (Electronic) IS - 1547-3287 (Print) IS - 1547-3287 (Linking) VI - 30 IP - 3 DP - 2021 Feb TI - Energy Metabolism During Osteogenic Differentiation: The Role of Akt. PG - 149-162 LID - 10.1089/scd.2020.0141 [doi] AB - Osteogenic differentiation, the process by which bone marrow mesenchymal stem/stromal (a.k.a. skeletal stem) cells and osteoprogenitors form osteoblasts, is a critical event for bone formation during development, fracture repair, and tissue maintenance. Extra cellular and intracellular signaling pathways triggering osteogenic differentiation are relatively well known; however, the ensuing change in cell energy metabolism is less clearly defined. We and others have previously reported activation of mitochondria during osteogenic differentiation. To further elucidate the involved bioenergetic mechanisms and triggers, we tested the effect of osteogenic media containing ascorbate and beta-glycerol phosphate, or various osteogenic hormones and growth factors on energy metabolism in long bone (ST2)- and calvarial bone (MC3T3-E1)-derived osteoprogenitors. We show that osteogenic media and differentiation factors, Wnt3a and BMP2, stimulate mitochondrial oxidative phosphorylation (OxPhos) with little effect on glycolysis. The activation of OxPhos occurs acutely, suggesting a metabolic signaling change rather than protein expression change. To this end, we found that the observed mitochondrial activation is Akt dependent. Akt is activated by osteogenic media, Wnt3a, and BMP2, leading to increased phosphorylation of various mitochondrial Akt targets, a phenomenon known to stimulate OxPhos. In sum, our data provide comprehensive analysis of cellular bioenergetics during osteoinduction in cells of two different origins (mesenchyme vs neural crest) and identify Wnt3a and BMP2 as physiological stimulators of mitochondrial respiration through Akt activation. FAU - Smith, Charles Owen AU - Smith CO AD - Center for Musculoskeletal Research, University of Rochester School of Medicine & Dentistry, Rochester, New York, USA. FAU - Eliseev, Roman A AU - Eliseev RA AD - Center for Musculoskeletal Research, University of Rochester School of Medicine & Dentistry, Rochester, New York, USA. LA - eng GR - R01 AR072601/AR/NIAMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20210111 PL - United States TA - Stem Cells Dev JT - Stem cells and development JID - 101197107 RN - 0 (Bone Morphogenetic Protein 2) RN - 0 (Wnt3A Protein) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) SB - IM MH - Animals MH - Blotting, Western MH - Bone Morphogenetic Protein 2/metabolism/pharmacology MH - Cell Differentiation/drug effects/*physiology MH - Cell Line MH - Energy Metabolism/drug effects/*physiology MH - Mesenchymal Stem Cells/cytology/metabolism/physiology MH - Mice MH - Mitochondria/metabolism MH - Osteoblasts/cytology/metabolism/physiology MH - Osteogenesis/drug effects/*physiology MH - Oxidative Phosphorylation MH - Proto-Oncogene Proteins c-akt/metabolism/*physiology MH - Signal Transduction/physiology MH - Stem Cells/cytology/metabolism/physiology MH - Wnt3A Protein/metabolism/pharmacology PMC - PMC7876359 OTO - NOTNLM OT - Akt OT - BMP2 OT - Wnt OT - differentiation OT - mitochondria OT - osteoblast COIS- The authors have nothing to disclose. EDAT- 2020/12/15 06:00 MHDA- 2021/12/15 06:00 PMCR- 2022/02/01 CRDT- 2020/12/14 09:50 PHST- 2020/12/15 06:00 [pubmed] PHST- 2021/12/15 06:00 [medline] PHST- 2020/12/14 09:50 [entrez] PHST- 2022/02/01 00:00 [pmc-release] AID - 10.1089/scd.2020.0141 [pii] AID - 10.1089/scd.2020.0141 [doi] PST - ppublish SO - Stem Cells Dev. 2021 Feb;30(3):149-162. doi: 10.1089/scd.2020.0141. Epub 2021 Jan 11.